J. B. Chemicals & Pharmaceuticals Limited
NSE: JBCHEPHARM BSE: JBCHEPHARM
NSE
1,782.60
-20.00 (-1.11%)
Prev Close
1802.6
Open Price
1802.6
Volume
198,162
Today Low / High
1780.2 / 1810.8
52 WK Low / High
1385.75 / 2030
Range
1,693 - 1,872
BSE
1,782.90
-19.55 (-1.08%)
Prev Close
1802.45
Open Price
1812.65
Volume
2,473
Today Low / High
1780.1 / 1812.65
52 WK Low / High
1303 / 2029
Range
1,694 - 1,872
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 1782.6 (target range: 1,693 - 1,872), reflecting a change of -20 (-1.10951%). On the BSE, it is listed at 1782.9 (target range: 1,694 - 1,872), showing a change of -19.55 (-1.08463%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
30 Jul
1,802.60
-1.11%
29 Jul
1,720.00
4.80%
28 Jul
1,710.00
-0.01%
25 Jul
1,704.50
0.21%
24 Jul
1,699.00
-0.20%
23 Jul
1,696.00
-0.41%
22 Jul
1,685.80
0.11%
21 Jul
1,654.00
1.86%
18 Jul
1,671.60
-1.05%
17 Jul
1,663.80
0.02%
16 Jul
1,642.00
0.80%
15 Jul
1,642.70
0.45%
14 Jul
1,612.00
1.61%
11 Jul
1,613.40
-0.30%
10 Jul
1,632.60
-1.11%
09 Jul
1,631.50
0.07%
08 Jul
1,631.20
-0.36%
07 Jul
1,635.00
-0.13%
04 Jul
1,632.10
0.37%
03 Jul
1,647.20
-0.47%
02 Jul
1,647.70
-0.40%
J. B. Chemicals & Pharmaceuticals Limited Graph
J. B. Chemicals & Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for J. B. Chemicals & Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,782.60, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 1,782.90 | 1,800.73 | 1,620.66 - 1,980.80 |
| 1,818.56 | 1,454.85 - 2,182.27 | ||
| 1,836.39 | 1,285.47 - 2,387.30 | ||
| Bearish Scenario | 1,782.90 | 1,765.07 | 1,588.56 - 1,941.58 |
| 1,747.24 | 1,397.79 - 2,096.69 | ||
| 1,729.41 | 1,210.59 - 2,248.24 |
Overview of J. B. Chemicals & Pharmaceuticals Limited
ISIN
INE572A01036
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
299,457
Market Cap
278,652,466,800
Last Dividend
22.25
Official Website
IPO Date
2002-07-01
DCF Diff
-811.43
DCF
2,594
Financial Ratios Every Investor Needs
Stock Dividend of JBCHEPHARM
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-07-30 | July 30, 25 | 7 | 7 | 2025-07-30 | 2025-08-13 | |
| 2025-02-07 | February 07, 25 | 8.5 | 8.5 | 2025-02-08 | 2025-02-21 | |
| 2024-08-14 | August 14, 24 | 6.75 | 6.75 | 2024-08-14 | 2024-09-20 | |
| 2024-02-16 | February 16, 24 | 5.5 | 5.5 | 2024-02-16 | 2024-03-07 | |
| 2023-08-17 | August 17, 23 | 4.625 | 9.25 | 2023-08-17 | 2023-09-23 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 3,917.99 Cr | 1,316.55 Cr | 2,601.44 Cr | 0.6640 | 0.00 Cr | 0.00 Cr | 1,913.83 Cr | 659.58 Cr | 42.45 | 1,031.84 Cr | 0.1683 |
| 2024-03-31 | 3,447.67 Cr | 2,121.75 Cr | 1,325.92 Cr | 0.3846 | 30.56 Cr | 33.70 Cr | 754.16 Cr | 552.63 Cr | 35.66 | 933.48 Cr | 0.1603 |
| 2023-03-31 | 3,149.28 Cr | 384.22 Cr | 2,765.06 Cr | 0.8780 | 31.93 Cr | 547.04 Cr | 591.79 Cr | 409.84 Cr | 26.50 | 704.37 Cr | 0.1301 |
| 2022-03-31 | 2,424.24 Cr | 863.37 Cr | 1,560.87 Cr | 0.6439 | 29.11 Cr | 57.99 Cr | 473.90 Cr | 385.36 Cr | 49.84 | 581.53 Cr | 0.1590 |
| 2021-03-31 | 2,005.85 Cr | 717.44 Cr | 1,288.41 Cr | 0.6423 | 23.53 Cr | 7.88 Cr | 489.54 Cr | 447.96 Cr | 57.96 | 672.26 Cr | 0.2233 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 129.45 Cr | 4,273.78 Cr | 840.46 Cr | 3,433.3200 Cr | 27.89 Cr | -101.56 Cr | 528.95 Cr | 656.64 Cr | 0.00 Cr | 0.00 Cr | 27.98 Cr | 632.3300 Cr |
| 2024-03-31 | 88.22 Cr | 3,994.13 Cr | 1,070.80 Cr | 2,923.3300 Cr | 377.66 Cr | 289.44 Cr | 502.51 Cr | 634.88 Cr | 12.99 Cr | 1.70 Cr | 23.71 Cr | 868.2261 Cr |
| 2023-03-31 | 76.93 Cr | 3,553.87 Cr | 1,073.52 Cr | 2,480.3500 Cr | 572.45 Cr | 495.52 Cr | 430.49 Cr | 576.42 Cr | 118.25 Cr | 15.21 Cr | 13.78 Cr | 554.4500 Cr |
| 2022-03-31 | 56.54 Cr | 2,607.40 Cr | 468.79 Cr | 2,134.1230 Cr | 54.56 Cr | -1.99 Cr | 409.96 Cr | 566.82 Cr | 116.47 Cr | 3.17 Cr | 12.72 Cr | 383.7156 Cr |
| 2021-03-31 | 28.69 Cr | 2,238.12 Cr | 424.69 Cr | 1,809.7248 Cr | 44.99 Cr | 16.30 Cr | 347.45 Cr | 569.66 Cr | 108.56 Cr | 4.93 Cr | 12.91 Cr | 345.2737 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 902.4500 Cr | -295.8900 Cr | -579.6800 Cr | 804.8600 Cr | 58.7181 Cr | 115.0900 Cr | -97.5900 Cr | 659.5800 Cr | -13.1000 Cr | -237.0400 Cr | -26.4400 Cr |
| 2024-03-31 | 800.6117 Cr | -403.8304 Cr | -374.0799 Cr | 539.2447 Cr | 11.2807 Cr | 88.2151 Cr | -126.1128 Cr | 552.6278 Cr | -191.5957 Cr | -156.9875 Cr | -72.0300 Cr |
| 2023-03-31 | 625.6100 Cr | -961.7900 Cr | 356.5400 Cr | -139.3400 Cr | 20.3900 Cr | 76.9300 Cr | -764.9500 Cr | 555.2300 Cr | 523.1596 Cr | -127.5926 Cr | -20.5200 Cr |
| 2022-03-31 | 170.1345 Cr | 2.3199 Cr | -138.3851 Cr | -536.6547 Cr | 34.0703 Cr | 56.5441 Cr | -706.7892 Cr | 504.9020 Cr | -0.3273 Cr | -127.5628 Cr | -62.5143 Cr |
| 2021-03-31 | 314.7849 Cr | -230.6758 Cr | -87.4228 Cr | 267.0119 Cr | -3.2782 Cr | 22.4737 Cr | -47.7730 Cr | 596.8854 Cr | 0.3223 Cr | -73.2403 Cr | -70.0857 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 949.48 Cr | 321.64 Cr | 627.84 Cr | 0.6612 | 451.02 Cr | 145.69 Cr | 9.36 | 222.76 Cr | 0.1534 |
| 2024-12-31 | 963.49 Cr | 316.74 Cr | 646.75 Cr | 0.6713 | 212.57 Cr | 162.49 Cr | 10.46 | 262.51 Cr | 0.1686 |
| 2024-09-30 | 1,000.62 Cr | 550.87 Cr | 449.75 Cr | 0.4495 | 228.64 Cr | 174.57 Cr | 11.24 | 280.47 Cr | 0.1745 |
| 2024-06-30 | 1,004.40 Cr | 547.44 Cr | 456.96 Cr | 0.4550 | 239.59 Cr | 176.83 Cr | 11.39 | 286.26 Cr | 0.1761 |
| 2024-03-31 | 861.73 Cr | 493.72 Cr | 368.01 Cr | 0.4271 | 157.38 Cr | 126.16 Cr | 8.22 | 214.75 Cr | 0.1464 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 129.45 Cr | 317.11 Cr | 446.56 Cr | 815.38 Cr | 528.95 Cr | 1,922.74 Cr | 656.64 Cr | 4,273.78 Cr | 840.46 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 416.86 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -3,212.23 Cr |
| 2024-09-30 | 89.89 Cr | 319.40 Cr | 416.86 Cr | 817.14 Cr | 543.67 Cr | 1,913.30 Cr | 641.67 Cr | 4,029.41 Cr | 817.18 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 459.64 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -2,923.33 Cr |
| 2024-03-31 | 95.54 Cr | 364.65 Cr | 460.19 Cr | 686.92 Cr | 502.51 Cr | 1,853.35 Cr | 634.88 Cr | 3,994.13 Cr | 1,070.80 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 145.69 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 162.49 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 174.57 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 176.83 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 126.16 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2023-09-18 | September 18, 23 | 2:1 |
| 2005-04-05 | April 05, 05 | 5:1 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,733.80 | ₹4,159,871,664,000.00 | ₹2,318,664.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,650.00 | ₹1,765,368,850,000.00 | ₹226,973.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,730.60 | ₹1,262,602,917,000.00 | ₹439,520.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,292.10 | ₹1,075,456,274,108.00 | ₹1,386,961.00 |
| Mankind Pharma Limited | MANKIND | ₹2,575.50 | ₹1,062,982,921,380.00 | ₹763,328.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹995.15 | ₹1,001,349,784,500.00 | ₹775,382.00 |
| Lupin Limited | LUPIN | ₹1,984.60 | ₹906,460,096,200.00 | ₹754,124.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,158.00 | ₹672,568,716,000.00 | ₹672,249.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,099.60 | ₹609,733,674,000.00 | ₹69,765.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,153.60 | ₹607,748,073,600.00 | ₹786,090.00 |
| Laurus Labs Limited | LAURUSLABS | ₹881.45 | ₹475,603,095,050.00 | ₹5,551,173.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,529.50 | ₹388,040,268,000.00 | ₹501,348.00 |
| Cohance Lifesciences Limited | COHANCE | ₹997.40 | ₹381,572,333,779.00 | ₹30,739.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,800.50 | ₹349,816,056,000.00 | ₹68,739.00 |
| Piramal Enterprises Limited | PEL | ₹1,287.60 | ₹291,870,592,800.00 | ₹4,377,271.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,782.60 | ₹278,652,466,800.00 | ₹198,162.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,684.80 | ₹273,744,619,200.00 | ₹253,355.00 |
| Eris Lifesciences Limited | ERIS | ₹1,816.60 | ₹247,415,470,200.00 | ₹258,998.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹9,340.00 | ₹233,500,000,000.00 | ₹39,783.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹1,007.60 | ₹198,056,878,800.00 | ₹43,245.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,236.30 | ₹196,919,100,300.00 | ₹1,978,762.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,910.00 | ₹178,463,909,000.00 | ₹72,265.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹973.15 | ₹174,300,896,500.00 | ₹709,365.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹2,145.80 | ₹163,105,905,860.00 | ₹121,630.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹492.15 | ₹119,417,244,600.00 | ₹954,418.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,947.00 | ₹98,716,631,800.00 | ₹41,877.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹919.15 | ₹89,884,505,735.00 | ₹41,687.00 |
| Strides Pharma Science Limited | STAR | ₹945.35 | ₹87,126,008,445.00 | ₹401,712.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹946.50 | ₹85,785,667,830.00 | ₹174,284.00 |
| FDC Limited | FDC | ₹484.45 | ₹78,873,304,500.00 | ₹30,593.00 |
| Suven Life Sciences Limited | SUVEN | ₹269.30 | ₹58,727,328,200.00 | ₹85,394.00 |
| Innova Captab Limited | INNOVACAP | ₹917.50 | ₹52,503,873,275.00 | ₹36,415.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹151.93 | ₹49,304,627,460.00 | ₹195,988.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹522.25 | ₹47,665,757,500.00 | ₹446,949.00 |
| Sequent Scientific Limited | SEQUENT | ₹175.86 | ₹44,023,913,100.00 | ₹235,318.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹619.85 | ₹43,641,035,130.00 | ₹39,695.00 |
| Hikal Limited | HIKAL | ₹329.80 | ₹40,664,669,800.00 | ₹316,649.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹404.55 | ₹40,567,464,900.00 | ₹352,761.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,405.80 | ₹39,789,526,200.00 | ₹52,499.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹705.15 | ₹35,764,573,365.00 | ₹37,012.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹59.69 | ₹32,707,374,260.00 | ₹1,444,289.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹651.90 | ₹31,390,940,700.00 | ₹124,331.00 |
| Indoco Remedies Limited | INDOCO | ₹324.50 | ₹29,934,443,550.00 | ₹64,322.00 |
| IOL Chemicals and Pharmaceuticals Limited | IOLCP | ₹100.29 | ₹29,437,822,830.00 | ₹15,953,556.00 |
| Alembic Limited | ALEMBICLTD | ₹114.24 | ₹29,334,775,566.00 | ₹212,418.00 |
Key Executives
Executive Vice President of Operations of Daman
Mr. Parmeshwar B. Bang
Gender: male
Year Born: 1968
Vice President of Legal
Mr. Himanshu Ranvah
Gender: male
Year Born: 1985
Vice President of Finance & Accounts
Mr. Bhagwat Singh Deora
Gender: male
Year Born: 1982
Vice President of Information & Technology
Mr. Suresh Bhise
Gender: male
Year Born: 1966
Vice President of HR & Administration
Mr. Sridhar Bharadwaj
Gender: male
Year Born: 1967
Chief Financial Officer
Mr. Narayan Saraf
Gender: male
Year Born: 1980
Assistant Vice President Human Resource
Suresh Amin
Gender: Not Specified
Year Born:
President of Operations
Mr. Kunal Khanna
Gender: male
Year Born: 1980
President of Global Business
Mr. Pradeep Kumar Singh
Gender: male
Year Born: 1964
Chief Executive Officer & Whole-Time Director
Mr. Nikhil Ashokkumar Chopra
Gender: male
Year Born: 1973
FAQs about J. B. Chemicals & Pharmaceuticals Limited
Who is the CEO of the company?
The CEO is Nikhil Ashokkumar Chopra.
What is the current market price of the stock?
The current price is ₹1,782.60.
What is the 52-week price range?
The range is ₹1385.75-2030.
What is the market capitalization of the company?
The market capitalization is ₹27,865.25 crores.
What is the dividend yield?
The dividend yield is 1.25%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 42.94.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of J. B. Chemicals & Pharmaceuticals Limited (ISIN: INE572A01036) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹27,865.25 crores and an average daily volume of 299,457 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹22.25.